Many types of cancer exhibit proliferative inflammatory atrophy in adjacent tissues, a condition resulting from inflammation and cellular damage that leads to the upregulation of the cell death regulatory protein Bcl-2 [27]. This evidence concerns the gene BCL2 and cancer.